# A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients

> **NCT00002374** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 120 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Ritonavir
- **DRUG:** Nelfinavir mesylate
- **DRUG:** Saquinavir
- **DRUG:** Stavudine

## Key facts

- **NCT ID:** NCT00002374
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 120 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002374, "A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00002374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*